Stay updated on FG-3019 in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the FG-3019 in Diabetic Kidney Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 is a minor version update replacing the previous v3.4.1, with no changes to study data or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedThe footer now displays Revision: v3.4.1, replacing Revision: v3.4.0. This is a cosmetic/maintenance update and does not modify study details or user interaction.SummaryDifference0.0%

- Check30 days agoChange DetectedUI updates include a Show glossary option, a revision/version notice, and capitalization tweaks to QC-related labels; these changes do not affect the core study information displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedSponsor changed from FibroGen to Kyntra Bio; page revision updated to v3.3.4.SummaryDifference0.2%

- Check65 days agoChange DetectedLocations were expanded to include state-by-state listings for Arizona, California, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Nebraska, New Jersey, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, and Washington. The page also now shows Revision: v3.3.3, replacing v3.3.2.SummaryDifference2%

- Check86 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. Core study details and page layout remain unchanged.SummaryDifference0.0%

Stay in the know with updates to FG-3019 in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.